Literature DB >> 23747168

Histopathological characteristics of stenosing flexor tenosynovitis in diabetic patients and possible associations with diabetes-related variables.

Makoto Kameyama1, Ko-Ron Chen, Kiyoshi Mukai, Akira Shimada, Yoshihito Atsumi, Shigeru Yanagimoto.   

Abstract

PURPOSE: To compare the histopathological findings of stenosing flexor tenosynovitis (SFTS) in diabetic patients with those in nondiabetic patients and to analyze the predominant characteristics of SFTS in diabetic patients by statistical methods.
METHODS: We included 63 patients (63 specimens) who underwent excision of A1 pulleys for SFTS. A total of 38 patients (38 digits) were diabetic and 25 (25 digits) were nondiabetic. We obtained specimens from the proximal one-third of each A1 pulley and analyzed them by histological and immunohistochemical methods. After we identified the predominant histopathological characteristics of SFTS in patients with diabetes, we performed multiple logistic regression analysis to examine the possible associations between the histopathological characteristics and diabetes-related variables.
RESULTS: We divided histopathological findings into 3 types in both diabetic and nondiabetic groups. Types 1 and 2 showed fibrocartilage metaplasia including fibrocartilage-like cells surrounded by basophilic extracellular substances. Type 2 was characterized by the presence of granulation tissue in the middle layer, which was not recognized in type 1. The granulation tissue contained newly formed microvessels, stromal cells, a small number of inflammatory cells, and extracellular matrix that showed myxomatous degeneration. Type 3 showed a decrease in fibrocartilage-like cells with surrounding extracellular eosinophilic substances, which was similar to hyaline degeneration. The histopathological features of type 2 were found in 68% of the diabetic group and in 28% of the nondiabetic group. This difference was statistically significant. The findings of type 2 were significantly associated with the severity of diabetic retinopathy and hemoglobin A1c values in the diabetic group.
CONCLUSIONS: Type 2 findings were more frequent in the diabetic group than in the nondiabetic group. A pathomechanism to accelerate neovascularization and hypercellularity in the granulation tissue in the middle layer of A1 pulley may exist, especially in diabetic patients with severe retinopathy and poorly controlled hyperglycemia.
Copyright © 2013 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23747168     DOI: 10.1016/j.jhsa.2013.03.049

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  5 in total

Review 1.  Alterations of tendons in diabetes mellitus: what are the current findings?

Authors:  Liu Shi; Yun-Feng Rui; Gang Li; Chen Wang
Journal:  Int Orthop       Date:  2015-05-06       Impact factor: 3.075

2.  Blood glucose levels in diabetic patients following corticosteroid injections into the hand and wrist.

Authors:  Jeffrey G Stepan; Daniel A London; Martin I Boyer; Ryan P Calfee
Journal:  J Hand Surg Am       Date:  2014-04       Impact factor: 2.230

Review 3.  The quality of control groups in nonrandomized studies published in the Journal of Hand Surgery.

Authors:  Shepard P Johnson; Sunitha Malay; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2014-10-16       Impact factor: 2.230

4.  Evaluation of apocynin in vitro on high glucose-induced oxidative stress on tenocytes.

Authors:  T Kurosawa; Y Mifune; A Inui; H Nishimoto; Y Ueda; T Kataoka; K Yamaura; S Mukohara; R Kuroda
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

5.  Impaired function of tendon-derived stem cells in experimental diabetes mellitus rat tendons: implications for cellular mechanism of diabetic tendon disorder.

Authors:  Liu Shi; Ying-Juan Li; Guang-Chun Dai; Yu-Cheng Lin; Gang Li; Chen Wang; Hui Chen; Yun-Feng Rui
Journal:  Stem Cell Res Ther       Date:  2019-01-15       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.